Corey Schrader
Private Equity Investor bei OrbiMed Advisors Private Equity
Ursprung des Netzwerks ersten Grades von Corey Schrader
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
74
| Subsidiary | Investment Managers | 74 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Corey Schrader
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Founder Founder Portfolio Manager-Equities Analyst-Equity Private Equity Investor Portfolio Manager-Equities Analyst-Equity Portfolio Manager-Fixed Income Trading-Equity Portfolio Manager-Equities | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| XTANT MEDICAL HOLDINGS, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SCISPARC LTD. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| ENTERO HEALTHCARE SOLUTIONS LIMITED | Medical Distributors | Director/Board Member Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| University College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Doctorate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Undergraduate Degree | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
Credit Suisse (Hong Kong) Ltd.
 Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Biotechnology | Chairman Director/Board Member | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| SCULPTOR CAPITAL MANAGEMENT, INC. | Investment Managers | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Emory University | College/University | Undergraduate Degree Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 40 |
| Vereinigtes Königreich | 4 |
| Israel | 4 |
| Kanada | 2 |
| Indien | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 15 |
| Finance | 8 |
| Distribution Services | 2 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 327 |
| Independent Dir/Board Member | 88 |
| Private Equity Investor | 79 |
| Corporate Officer/Principal | 77 |
| Undergraduate Degree | 66 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jonathan Silverstein | 42 |
| Peter Thompson | 39 |
| Erez Chimovits | 30 |
| Iain Dukes | 30 |
| Sunny Sharma | 29 |
| Rishi Gupta | 29 |
| Guo-Liang Yu | 27 |
| David Bonita | 27 |
| Dina Chaya | 23 |
| Sheila Gujrathi | 20 |
| Klaus Veitinger | 18 |
| Michael Bart Sheffery | 16 |
| Kevin Koch | 15 |
| Ronny Ginor | 14 |
- Börse
- Insiders
- Corey Schrader
- Unternehmensverbindungen
